KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 1 filers reported holding KALA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $7,881 | -78.0% | 25,874 | 0.0% | 0.00% | -66.7% |
Q1 2022 | $35,853 | +128.8% | 25,874 | 0.0% | 0.00% | +50.0% |
Q4 2021 | $15,670 | -53.8% | 25,874 | 0.0% | 0.00% | -60.0% |
Q3 2021 | $33,929 | -50.6% | 25,874 | 0.0% | 0.01% | -50.0% |
Q2 2021 | $68,635 | -21.4% | 25,874 | 0.0% | 0.01% | -28.6% |
Q1 2021 | $87,282 | -0.6% | 25,874 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $87,801 | -9.6% | 25,874 | 0.0% | 0.01% | -41.7% |
Q3 2020 | $97,125 | +56.8% | 25,874 | +119.8% | 0.02% | +14.3% |
Q2 2020 | $61,934 | +19.6% | 11,774 | 0.0% | 0.02% | -4.5% |
Q1 2020 | $51,799 | +138.2% | 11,774 | 0.0% | 0.02% | +175.0% |
Q4 2019 | $21,745 | -3.0% | 11,774 | 0.0% | 0.01% | -20.0% |
Q3 2019 | $22,422 | -40.4% | 11,774 | 0.0% | 0.01% | -47.4% |
Q2 2019 | $37,597 | -22.9% | 11,774 | 0.0% | 0.02% | -26.9% |
Q1 2019 | $48,734 | +69.1% | 11,774 | 0.0% | 0.03% | +73.3% |
Q4 2018 | $28,816 | -50.5% | 11,774 | 0.0% | 0.02% | -53.1% |
Q3 2018 | $58,163 | -28.1% | 11,774 | 0.0% | 0.03% | -45.8% |
Q2 2018 | $80,910 | +56.1% | 11,774 | +80.0% | 0.06% | +47.5% |
Q1 2018 | $51,832 | – | 6,542 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 1,430,021 | $9,638,000 | 6.26% |
RA Capital Management | 10,874,613 | $73,295,000 | 1.10% |
Mesirow Financial Investment Management, Inc. | 41,961 | $283,000 | 0.77% |
Samsara BioCapital, LLC | 601,162 | $4,052,000 | 0.75% |
SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $689,000 | 0.38% |
Eventide Asset Management | 3,450,000 | $23,253,000 | 0.34% |
Orbimed Advisors | 5,465,030 | $36,834,000 | 0.34% |
Parkman Healthcare Partners LLC | 148,433 | $1,000,000 | 0.23% |
Vivo Capital, LLC | 786,883 | $5,304,000 | 0.19% |
Knights of Columbus Asset Advisors LLC | 199,954 | $1,348,000 | 0.13% |